Steakholder Foods Ltd logo

Steakholder Foods Ltd(STKH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$1.93
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for STKH

11/13/2026: STKH (1-star) is currently NOT-A-BUY. Pass it for now.

Steakholder Foods Ltd is a speculative, early-stage food technology company focused on 3D bioprinting and cultivated meat production. The company’s primary strength lies in its proprietary intellectual property and its strategic pivot toward licensing its technology to larger food manufacturers, which could offer a more capital-efficient path to growth. The primary investment story rests on the potential for cultivated meat to capture market share as production costs fall and regulatory hurdles are cleared. However, investors face significant execution, valuation, and regulatory risks, as the business is not yet commercially viable. It is best suited for high-risk growth investors who should closely monitor upcoming partnerships and regulatory milestones.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe company is in an extremely early, high-risk R&D stage with no proven path to profitability.
Momentum investorWeak fitMomentum signals are generally poor for stocks with limited commercial traction and high volatility.
Value investorWeak fitThe company lacks the earnings or cash flow history required for value investing.
Dividend investorWeak fitThe company does not pay dividends and is unlikely to do so in the foreseeable future.
Low-risk investorWeak fitHigh volatility and the speculative nature of the technology present significant risk to capital preservation.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock is highly sensitive to speculative news and sector sentiment.
Valuation riskHighWithout revenue, traditional valuation metrics are not applicable, making the stock highly prone to correction.
Competition risk (Biotech / Alt-Meat)Medium / highThe company faces competition from better-capitalized incumbents and well-funded startups.
Business qualityMediumThe technology is innovative, but the commercial business model remains unproven at scale.
Dividend incomeLow / noneThere is no income generation for investors.
Execution riskHighSuccessfully transitioning from lab prototypes to industrial-scale manufacturing is extremely difficult.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.10M USD
Price to earnings Ratio 0.02
1Y Target Price -
Price to earnings Ratio 0.02
1Y Target Price -
Volume (30-day avg) 165.0K shares
Beta -16.18
52 Weeks Range 1.50 - 61.35
Updated Date 11/14/2026
52 Weeks Range 1.50 - 61.35
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) 96

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.0%
Active BUY / eligible
19 / 20
30-Day BUY Count Change
+13
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Industry classification is unavailable for this snapshot.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -47.1%
Avg. Invested days 13
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
STKH receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
STKH has moderate overall fundamentals (3 stars), with moderate financial health, soft growth momentum, and solid ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-32.0%), soft cash generation (FCF margin 0.0%), negative revenue growth (-100.0%).

Financial Health Rating

★★★★★
STKH's financial health is supported by strong efficiency, including operating-expense and cost-of-revenue discipline (opex 0.0% of revenue). Profitability is weak (1 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is STKH's strongest growth driver at +27.4% FY2025 versus FY2024 (solid, 4 stars). By comparison, while revenue growth (-100.0%, negative) and earnings growth (-32.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 1.1% and approximately 1036683.4% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 10.97% supports management-shareholder alignment.

Top 5 Institutional Investors

Renaissance Technologies Corp 0.41%
SmartHarvest Portfolios, LLC 0.34%
UBS Group AG 0.18%
Rhumbline Advisers 0.15%
Westside Investment Management, Inc. 0.04%

Unit Economics (Per $1K Revenue)

★★★★★
STKH generates approximately $-0 of gross profit, $-0 of operating income, and $-0 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
STKH has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Technology LicensingLicensing 3D bioprinting hardware and processes to food producers.The company is betting on selling the 'picks and shovels' for the lab-grown meat industry.

Valuation

Trailing PE 0.02
Forward PE -
Enterprise Value 21.75M
Price to Sales(TTM) 53.38
Enterprise Value 21.75M
Price to Sales(TTM) 53.38
Enterprise Value to Revenue 558.13
Enterprise Value to EBITDA 0.46
Shares Outstanding 568.57K
Shares Floating 5.89B
Shares Outstanding 568.57K
Shares Floating 5.89B
Percent Insiders 10.97
Percent Institutions 1.07

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.